Mutations in a gene called OTP cause obesity by controlling the output of another gene already targeted by an anti-obesity drug, a study led by UT Southwestern Medical Center researchers shows. The ...
The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...
(RTTNews) - Rhythm Pharmaceuticals, Inc. (RYTM) Friday said it expects full-year product revenue of about $130 million, higher than $77.4 million reported in the previous year. For the fourth quarter, ...